Integrative oncology for breast cancer patients: introduction of an expert-based model

por Dobos, Gustav J, Voiss, Petra, Schwidde, Ilka, Choi, Kyung-Eun, Paul, Anna, Kirschbaum, Barbara, Saha, Felix J, Kuemmel, Sherko
Publicado 2012

Olaparib for metastatic breast cancer in a patient with a germline PALB2 variant

por Kuemmel, Sherko, Harrach, Hakima, Schmutzler, Rita K., Kostara, Athina, Ziegler-Löhr, Katja, Dyson, Mark H., Chiari, Ouafaa, Reinisch, Mattea
Publicado 2020

Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers

por Reinisch, Mattea, Kuemmel, Sherko, Breit, Elisabeth, Theuerkauf, Ingo, Harrach, Hakima, Schindowski, Dorothea, Moka, Detlef, Bettstetter, Marcus, Bruzas, Simona, Chiari, Ouafaa
Publicado 2021

Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary bre...

por Reinisch, Mattea, Bruzas, Simona, Spoenlein, Jennifer, Shenoy, Satyendra, Traut, Alexander, Harrach, Hakima, Chiari, Ouafaa, Cremer, Efsthatia, Ataseven, Beyhan, Gubelt, Lars, Kuemmel, Sherko
Publicado 2023

Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice

por Bruzas, Simona, Kuemmel, Sherko, Harrach, Hakima, Breit, Elisabeth, Ataseven, Beyhan, Traut, Alexander, Rüland, Anna, Kostara, Athina, Chiari, Ouafaa, Dittmer-Grabowski, Christine, Reinisch, Mattea
Publicado 2021

Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Advanced Breast Cancer: A Systematic Literature Review

por Cuyún Carter, Gebra, Mohanty, Maitreyee, Stenger, Keri, Morato Guimaraes, Claudia, Singuru, Shivaprasad, Basa, Pradeep, Singh, Sheena, Tongbram, Vanita, Kuemmel, Sherko, Guarneri, Valentina, Tolaney, Sara M
Publicado 2021

Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Ex...

por Arboleda, Bolivar, Bartsch, Rupert, de Azambuja, Evandro, Hamilton, Erika, Harbeck, Nadia, Klemp, Jennifer, Knauer, Michael, Kuemmel, Sherko, Mahtani, Reshma, Schwartzberg, Lee, Villarreal-Garza, Cynthia, Wolff, Antonio
Publicado 2022

ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer

por Grote, Isabel, Bartels, Stephan, Christgen, Henriette, Radner, Martin, Gronewold, Malte, Kandt, Leonie, Raap, Mieke, Lehmann, Ulrich, Gluz, Oleg, Graeser, Monika, Kuemmel, Sherko, Nitz, Ulrike, Harbeck, Nadia, Kreipe, Hans, Christgen, Matthias
Publicado 2022

Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy

por Reinisch, Mattea, Bruzas, Simona, Gluz, Oleg, Ataseven, Beyhan, Schmid, Peter, Cortés, Javier, Blohmer, Jens‐Uwe, Shenoy, Satyendra, Dyson, Mark H., Dittmer‐Grabowski, Christine, Chiari, Ouafaa, Harrach, Hakima, Gebauer, Daniel, Traut, Alexander, Kuemmel, Sherko
Publicado 2023

Gene signatures in patients with early breast cancer and relapse despite pathologic complete response

por Bruzas, Simona, Gluz, Oleg, Harbeck, Nadia, Schmid, Peter, Cortés, Javier, Blohmer, Jens, Seiberling, Christine, Chiari, Ouafaa, Harrach, Hakima, Ataseven, Beyhan, Shenoy, Satyendra, Dyson, Mark H., Traut, Eugen, Theuerkauf, Ingo, Gebauer, Daniel, Kuemmel, Sherko, Reinisch, Mattea
Publicado 2022

RESPONDER – diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-in...

por Heil, Joerg, Sinn, Peter, Richter, Hannah, Pfob, André, Schaefgen, Benedikt, Hennigs, André, Riedel, Fabian, Thomas, Bettina, Thill, Marc, Hahn, Markus, Blohmer, Jens-Uwe, Kuemmel, Sherko, Karsten, Maria Margarete, Reinisch, Mattea, Hackmann, John, Reimer, Toralf, Rauch, Geraldine, Golatta, Michael
Publicado 2018

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study

por Kuemmel, Sherko, Tondini, Carlo A., Abraham, Jacinta, Nowecki, Zbigniew, Itrych, Bartosz, Hitre, Erika, Karaszewska, Bogusława, Juárez-Ramiro, Alejandro, Morales-Vásquez, Flavia, Pérez-García, Jose Manuel, Cardona-Huerta, Servando, Monturus, Estefania, Sequi, Marco, Restuccia, Eleonora, Benyunes, Mark, Martín, Miguel
Publicado 2021

Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

por Kolberg-Liedtke, Cornelia, Feuerhake, Friedrich, Garke, Madlen, Christgen, Matthias, Kates, Ronald, Grischke, Eva Maria, Forstbauer, Helmut, Braun, Michael, Warm, Mathias, Hackmann, John, Uleer, Christoph, Aktas, Bahriye, Schumacher, Claudia, Kuemmel, Sherko, Wuerstlein, Rachel, Graeser, Monika, Nitz, Ulrike, Kreipe, Hans, Gluz, Oleg, Harbeck, Nadia
Publicado 2022

Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West Germa...

por Nitz, Ulrike, Gluz, Oleg, Christgen, Matthias, Kates, Ronald E., Clemens, Michael, Malter, Wolfram, Nuding, Benno, Aktas, Bahriye, Kuemmel, Sherko, Reimer, Toralf, Stefek, Andrea, Lorenz-Salehi, Fatemeh, Krabisch, Petra, Just, Marianne, Augustin, Doris, Liedtke, Cornelia, Chao, Calvin, Shak, Steven, Wuerstlein, Rachel, Kreipe, Hans H., Harbeck, Nadia
Publicado 2017

Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised pha...

por Nitz, Ulrike, Gluz, Oleg, Christgen, Matthias, Kates, Ronald E., Clemens, Michael, Malter, Wolfram, Nuding, Benno, Aktas, Bahriye, Kuemmel, Sherko, Reimer, Toralf, Stefek, Andrea, Lorenz-Salehi, Fatemeh, Krabisch, Petra, Just, Marianne, Augustin, Doris, Liedtke, Cornelia, Chao, Calvin, Shak, Steven, Wuerstlein, Rachel, Kreipe, Hans H., Harbeck, Nadia
Publicado 2019

Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic

por Dowsett, Mitch, Ellis, Matthew J., Dixon, J. Michael, Gluz, Oleg, Robertson, John, Kates, Ronald, Suman, Vera J., Turnbull, Arran K., Nitz, Ulrike, Christgen, Matthias, Kreipe, Hans, Kuemmel, Sherko, Bliss, Judith M., Barry, Peter, Johnston, Stephen R., Jacobs, Samuel A., Ma, Cynthia X., Smith, Ian E., Harbeck, Nadia
Publicado 2020

Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial

por Graeser, Monika, Feuerhake, Friedrich, Gluz, Oleg, Volk, Valery, Hauptmann, Michael, Jozwiak, Katarzyna, Christgen, Matthias, Kuemmel, Sherko, Grischke, Eva-Maria, Forstbauer, Helmut, Braun, Michael, Warm, Mathias, Hackmann, John, Uleer, Christoph, Aktas, Bahriye, Schumacher, Claudia, Kolberg-Liedtke, Cornelia, Kates, Ronald, Wuerstlein, Rachel, Nitz, Ulrike, Kreipe, Hans Heinrich, Harbeck, Nadia
Publicado 2021

Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer

por Harbeck, Nadia, von Schumann, Raquel, Kates, Ronald Ernest, Braun, Michael, Kuemmel, Sherko, Schumacher, Claudia, Potenberg, Jochem, Malter, Wolfram, Augustin, Doris, Aktas, Bahriye, Forstbauer, Helmut, Tio, Joke, Grischke, Eva-Maria, Biehl, Claudia, Liedtke, Cornelia, De Haas, Sanne Lysbet, Deurloo, Regula, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Gluz, Oleg
Publicado 2021

The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized t...

por Nitz, Ulrike, Gluz, Oleg, Kreipe, Hans H., Christgen, Matthias, Kuemmel, Sherko, Baehner, Frederick L., Shak, Steven, Aktas, Bahriye, Braun, Michael, Lüdtke-Heckenkamp, Kerstin, Forstbauer, Helmut, Grischke, Eva-Maria, Nuding, Benno, Darsow, Maren, Schumacher, Claudia, Krauss, Katja, Malter, Wolfram, Thill, Marc, Warm, Mathias, Wuerstlein, Rachel, Kates, Ronald E., Harbeck, Nadia
Publicado 2020

TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer

por Grote, Isabel, Bartels, Stephan, Kandt, Leonie, Bollmann, Laura, Christgen, Henriette, Gronewold, Malte, Raap, Mieke, Lehmann, Ulrich, Gluz, Oleg, Nitz, Ulrike, Kuemmel, Sherko, zu Eulenburg, Christine, Braun, Michael, Aktas, Bahriye, Grischke, Eva‐Maria, Schumacher, Claudia, Luedtke‐Heckenkamp, Kerstin, Kates, Ronald, Wuerstlein, Rachel, Graeser, Monika, Harbeck, Nadia, Christgen, Matthias, Kreipe, Hans
Publicado 2021